<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82202">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01782248</url>
  </required_header>
  <id_info>
    <org_study_id>5289</org_study_id>
    <secondary_id>5289</secondary_id>
    <nct_id>NCT01782248</nct_id>
  </id_info>
  <brief_title>Self-consciousness in Dementia</brief_title>
  <official_title>Self-consciousness in Dementia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Ministry of Health (National Agency for the safety of drugs and Health products)</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to characterize the deficit in critical components of personal
      identity (self-consciousness and social cognition) in patients with Alzheimer's disease (AD)
      and fronto-temporal lobar dementia (FTLD), compared to healthy elderly, combining a
      neuropsychology and multi-podal neuroimaging study.

      We posit that the alteration of some aspects of self-consciousness (autobiographical memory,
      nosognosia, metacognition) and social cognition (theory of mind and facial) results in
      personality changes in the patients, primarily due to the alteration of self-consciousness
      in AD and to social cognition in FTLD.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>Phase 0</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Characterize the deficit in critical components of personal identity in patients with Alzheimer's disease (AD) and fronto-temporal lobar dementia (FTLD), compared to healthy elderly, combining a neuropsychology and multi-podal neuroimaging study.</measure>
    <time_frame>each month for 3 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Alzheimer Disease</condition>
  <condition>Fronto-temporal Lobar Dementia</condition>
  <arm_group>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with Alzheimer disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fronto-temporal lobar dementia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with Fronto-temporal lobar dementia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnary and IRM</intervention_name>
    <arm_group_label>Alzheimer disease</arm_group_label>
    <arm_group_label>Fronto-temporal lobar dementia</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  AD (McKhann et al, 1984 and Dubois et al, 2007) or FTLD (Neary et al, 1998 or
             Rascovsky et al, 2011)

          -  MMSE &gt; or = 18

          -  Relative avaible

        Exclusion Criteria:

          -  Contraindication to MRI

          -  Major depression

          -  Other central neurological condition
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nathalie PHILIPPI, MD</last_name>
    <phone>3 88 12 86 33</phone>
    <phone_ext>+33</phone_ext>
    <email>nathalie.philippi@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>HÃ´pitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie PHILIPPI, MD</last_name>
      <phone>3 88 12 86 33</phone>
      <phone_ext>+33</phone_ext>
      <email>nathalie.philippi@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 30, 2013</lastchanged_date>
  <firstreceived_date>October 15, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
